دورية أكاديمية
[Economic evaluation for the prevention of cervical cancer by vaccination--from perspective of health insurance society and industry].
| العنوان: | [Economic evaluation for the prevention of cervical cancer by vaccination--from perspective of health insurance society and industry]. |
|---|---|
| المؤلفون: | Kawabayashi Y; Faculty of Pharmaceutical Science, Teikyo Heisei University., Furuno M, Uchida M, Kawana T |
| المصدر: | Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2013 Apr; Vol. 40 (4), pp. 493-8. |
| نوع المنشور: | English Abstract; Journal Article |
| اللغة: | Japanese |
| بيانات الدورية: | Publisher: Gan To Kagaku Ryohosha Country of Publication: Japan NLM ID: 7810034 Publication Model: Print Cited Medium: Print ISSN: 0385-0684 (Print) Linking ISSN: 03850684 NLM ISO Abbreviation: Gan To Kagaku Ryoho Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Tokyo : Gan To Kagaku Ryohosha Original Publication: Tōkyō, Gan to Kagaku Ryōhōsha [1974?]- |
| مواضيع طبية MeSH: | Health Benefit Plans, Employee/*economics , Uterine Cervical Neoplasms/*prevention & control , Vaccination/*economics, Adolescent ; Adult ; Cancer Vaccines ; Cost-Benefit Analysis ; Female ; Humans ; Industry/economics ; Japan ; Models, Theoretical ; Uterine Cervical Neoplasms/economics |
| مستخلص: | Objective: The aim of this study is to estimate the budget impact in a health insurance society and an industry of promoting decision-making for endowing grants for vaccination as prophylaxis against cervical cancer (CC) by the health insurance society for employees. Methods: The target population was Japanese female employees aged 20 to 34 and partners and daughters of male employees working for an overseas IT industry. By using a prevalence-based model, the author estimated expected costs in non-vaccination and vaccination scenarios and evaluated the 10-year financial impact on the industry after vaccination by employing a cost-benefit analysis. The incidence of CC in a target group was derived from the actual number of patients with CC in addition to data from JMDC's receipt database and estimated by a Bayesian method. The epidemiological parameters such as mortality rate, screening rate, detailed exam rate and detailed exam consultation rate were taken from epidemiology statistics and published articles available in Japan. Healthcare costs for cancer treatment, screening, detailed exam and vaccination estimated based on medical fee points were input into the model, 'but the analysis did not consider side effect-related costs. In addition, productivity costs for mortality in employees and their families due to CC, estimated by the national employee's statistics, were also input into the model. An annual discount was unconsidered. Results: From the perspective of the healthcare insurance society, expenditure of approximately 129 million yen in the non-vaccination scenario was expected for ten years, but healthcare-related costs were saved by expenditure of approximately 73 million yen with 100% of employees and their families being vaccinated at expenses of approximately 55 million yen. The insurance society lost approximately 1.8 million yen in total if subsidy for vaccination was set at ten thousand yen. In the case of a 100% vaccination rate, the company can save losses in productivity of approximately 563 million yen in ten years as compared with non-inoculation. Furthermore, family finance can save approximately 2.6 million yen, based on our analysis. Sensitivity analyses suggested that subsidy expenses, the uptake rate of vaccination, and time horizon influenced the mortality cost from the perspectives of the company and the employees' families. Conclusion: A grant for vaccinating women, who are an untargeted population for a public grant, by the health insurance society is meaningful for the prevention of CC. It was deemed that a grant for vaccination of women by the health insurance society would be approximately ten thousand yen. |
| المشرفين على المادة: | 0 (Cancer Vaccines) |
| تواريخ الأحداث: | Date Created: 20130716 Date Completed: 20130807 Latest Revision: 20130715 |
| رمز التحديث: | 20221213 |
| PMID: | 23848018 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0385-0684 |
|---|